| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | 0.00094 | 1 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.00062 | 1 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | 0.00049 | 1 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.00036 | 1 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.00026 | 1 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.00026 | 1 |